Authors:
Ashraf, H
Hildebrand, P
Meier, R
Beglinger, C
Gyr, N
Citation: H. Ashraf et al., Induction of artificial fat maldigestion by tetrahydrolipstatin assessed by the C-13-hiolein breath test in healthy volunteers - A double-blind controlled pilot study, DIGESTION, 62(2-3), 2000, pp. 159-163
Authors:
Metzger, J
Degen, L
Beglinger, C
von Flue, M
Harder, F
Citation: J. Metzger et al., Clinical outcome and quality of life after gastric and distal esophagus replacement with an ileocolon interposition, J GASTRO S, 3(4), 1999, pp. 383-388
Authors:
Heizmann, G
Hildebrand, P
Tanner, H
Ketterer, S
Pansky, A
Froidevaux, S
Beglinger, C
Eberle, AN
Citation: G. Heizmann et al., A combinatorial peptoid library for the identification of novel MSH and GRP/bombesin receptor ligands, J RECEPT SI, 19(1-4), 1999, pp. 449-466
Authors:
Lehmann, F
Drewe, J
Terracciano, L
Stuber, R
Frei, R
Beglinger, C
Citation: F. Lehmann et al., Comparison of stool immunoassay with standard methods for detecting Helicobacter pylori infection, BR MED J, 319(7222), 1999, pp. 1409-1409
Authors:
Gutzwiller, JP
Drewe, J
Goke, B
Schmidt, H
Rohrer, B
Lareida, J
Beglinger, C
Citation: Jp. Gutzwiller et al., Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2, AM J P-REG, 45(5), 1999, pp. R1541-R1544
Authors:
Matzinger, D
Gutzwiller, JP
Drewe, J
Orban, A
Engel, R
D'Amato, M
Rovati, L
Beglinger, C
Citation: D. Matzinger et al., Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans, AM J P-REG, 277(6), 1999, pp. R1718-R1724
Authors:
Ritz, MA
Drewe, J
Ziel, A
Hildebrand, P
Schneider, P
Lahlou, N
Beglinger, C
Citation: Ma. Ritz et al., The effects of vapreotide, a somatostatin analogue, on gastric acidity, gallbladder emptying and hormone release after 1 week of continuous subcutaneous infusion in normal subjects, BR J CL PH, 47(2), 1999, pp. 195-201
Authors:
Gutmann, H
Torok, M
Fricker, G
Huwyler, J
Beglinger, C
Drewe, J
Citation: H. Gutmann et al., Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro, DRUG META D, 27(8), 1999, pp. 937-941
Authors:
Lochs, H
Adler, G
Beglinger, C
Duchmann, R
Emmrich, J
Ewe, K
Gangl, A
Gasche, C
Hahn, E
Hoffmann, P
Kaskas, B
Malchow, H
Pohl, C
Raedler, A
Renner, E
Scholmerich, J
Schreiber, S
Stange, E
Tilg, H
Vogelsang, H
Weigert, N
Zeitz, M
Citation: H. Lochs et al., Anti-TNF antibody in Crohn's disease - status of information, comments andrecommendations of an international working group, Z GASTROENT, 37(6), 1999, pp. 509-512
Citation: Fs. Lehmann et C. Beglinger, Prevention and treatment of NSAID-induced ulcers: the present position, SCHW MED WO, 129(29-30), 1999, pp. 1073-1080
Authors:
Beltinger, J
Hildebrand, P
Drewe, J
Christ, A
Hlobil, K
Ritz, M
D'Amato, M
Rovati, L
Beglinger, C
Citation: J. Beltinger et al., Effects of spiroglumide, a gastrin receptor antagonist, on acid secretion in humans, EUR J CL IN, 29(2), 1999, pp. 153-159
Authors:
Vader, JP
Froehlich, F
Dubois, RW
Beglinger, C
Wietlisbach, V
Pittet, V
Ebel, N
Gonvers, JJ
Burnand, B
Citation: Jp. Vader et al., European panel on the appropriateness of gastrointestinal endoscopy (EPAGE): Conclusion and WWW site, ENDOSCOPY, 31(8), 1999, pp. 687-694
Citation: C. Beglinger et J. Drewe, Somatostatin and octreotide: Physiological background and pharmacological application, DIGESTION, 60, 1999, pp. 2-8
Authors:
Drewe, J
Sieber, CC
Mottet, C
Wullschleger, C
Larsen, F
Beglinger, C
Citation: J. Drewe et al., Dose-dependent gastrointestinal effects of the somatostatin analog lanreotide in healthy volunteers, CLIN PHARM, 65(4), 1999, pp. 413-419
Authors:
Froidevaux, S
Hintermann, E
Torok, M
Macke, HR
Beglinger, C
Eberle, AN
Citation: S. Froidevaux et al., Differential regulation of somatostatin receptor type 2 (sst 2) expressionin AR4-2J tumor cells implanted into mice during octreotide treatment, CANCER RES, 59(15), 1999, pp. 3652-3657
Authors:
Drewe, J
Gutmann, H
Fricker, G
Torok, M
Beglinger, C
Huwyler, J
Citation: J. Drewe et al., HIV protease inhibitor ritonavir: A more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833, BIOCH PHARM, 57(10), 1999, pp. 1147-1152